AstraZeneca is starting to profit from sales of its Covid-19 vaccine
By Walé Azeez, CNN Business AstraZeneca has booked its first profit from sales of its Covid-19 vaccine. The company sold $2.2 billion worth of the shot in the first nine months of the year. In the quarter ending September 30, the vaccine’s sales totaled $1.05 billion, contributing one cent to earnings per share. Announcing its
Continue Reading